
Festival of Biologics 2023
MEET KACTUS AT THE FESTIVAL OF BIOLOGICS 2023. San Diego, CA March 20-22 Booth #55 What is Festival of Biologics? Festival of Biologics u...
Read moreMEET KACTUS AT THE FESTIVAL OF BIOLOGICS 2023. San Diego, CA March 20-22 Booth #55 What is Festival of Biologics? Festival of Biologics u...
Read moreColorectal cancer (CRC) is the third most common tumor and the most common tumor of the digestive system. With the advancement of medical intervent...
Read moreThe process of tumor cell infiltration, adhesion and migration is an important research direction in the process of drug development. CUB domain co...
Read moreOn December 19, 2022, the FDA approved the Phase I/IIa clinical trial application of IVS-3001, an anti-HLA-G CAR-T cell therapy developed by Invect...
Read moreThe tumor necrosis factor (TNF) superfamily has important physiological significance in immune surveillance, tumor regression, resistance to infect...
Read moreAlkaline Phosphatase Alkaline Phosphatase (ALP) likely represents the most frequently assayed enzyme in all of medicine. It is widely distributed ...
Read moreMarch 7-9th 2023: Meet us at TIDES Asia in Kyoto, Japan KACTUS will be at TIDES Asia in Kyoto at booth #12 on March 7-9th. TIDES is a prominent con...
Read moreOn January 4, 2023, Shanghai Jiyu Pharmaceutical announced that the IND application for its Class 1 drug JYB1907, GARP-TGF-β1 monoclonal antibody i...
Read moreAbout FLT3 Fms-like tyrosine kinase 3 (FLT3) is also known as CD135 (Cluster of differentiation antigen 135) and FLK2 (Fetal liver kinase-2). It is...
Read moreDKK1 (Dickkopf-related protein 1, or Soggy) is a secreted glycoprotein that contains two conserved cysteine-rich domains CRD-1 and CRD-2 (also know...
Read moreAfter successful completion of DMF filings for our CRISPR Cas9 enzyme and Maxnuclease in the first half of 2022, we are excited to add two new ...
Read moreFigure 1. MAGE-A4 Protein Recently at the 2022 CTOS Conference, Adaptimmune announced the SPEARHEAD-1 clinical trial data of its TCR-T therapy, A...
Read more